Genovis AB (GENO) NPV
Sell:24.75 SEKBuy:24.85 SEK
0.55 SEK
(2.25%)
- This stock can be held in a
Stocks and Shares ISA0.55 SEK
(2.25%)0.55 SEK
(2.25%)Company Information
About this company
Genovis AB is a Sweden-based company engaged in the research and development, production and marketing of technologies and products for cellular research. The Company offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The Company markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.
Key people
Key facts
- EPIC-
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINSE0002485979
- Market capSEK 1.60bn
- Employees32
- Shares in issue65.47m
- ExchangeStockholm Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.